Report Summary
Eternity Insights has published a new study on Global Computational Medicine And Drug Discovery Software Market focusing on key segments as by Type (Database, Software, Others), by Application (Computational Physiological Medicine, Drug Discovery And Development, Medical Imaging, Disease Modeling, Predictive Analysis Of Drug Targets, Cellular Simulation, Simulation Software), and by region. This deep dive re-search report highlights the market and competitive intelligence across the key segments of the mar-ket. The report also considers the impact of COVID-19 on the global Computational Medicine And Drug Discovery Software Market.
The report considers 2018-2020 as historic period, 2021 as base year, and 2022-2028 as forecast period. The report includes quantitative analysis of the market supported by the market drivers, challenges, and trends to accurately map the market scenario and competition. Moreover, key insights related to market having direct impact on the market will also be covered.
Computational Medicine And Drug Discovery Software Market report is based on robust research methodology designed using blend of research ap-proaches developed using secondary/desk research and validated through the primary research and expert insights. Eternity Insights also uses paid data bases such as FACIVA, Hoovers, and other bench-marking and forecasting tools to provide accurate statistical analysis of supply and demand trends.
Global Computational Medicine And Drug Discovery Software Market Size, 2018-2028 (USD Million)
To learn more about this report
Global Computational Medicine And Drug Discovery Software Market Segmentation:
Computational Medicine And Drug Discovery Software Market, By Type
Computational Medicine And Drug Discovery Software Market, By Application
- Computational Physiological Medicine
- Drug Discovery And Development
- Medical Imaging
- Disease Modeling
- Predictive Analysis Of Drug Targets
- Cellular Simulation
- Simulation Software
To learn more about this report
Geographically, the market is categorized in to five regions as North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. North America region dominates the global Computational Medicine And Drug Discovery Software market in terms of demand generation. The Computational Medicine And Drug Discovery Software market in Asia Pacific region is expected to grow at significantly high growth rate. The regional market is further sub-segmented and analyzed at granular level across key countries. The report will include market size and forecast for Computational Medicine And Drug Discovery Software market for below listed coun-tries across each region.
North America (U.S. and Canada), Europe (Germany, France, Italy, UK, Spain, and Rest of Europe), Asia Pacific (China, India, Japan, Australia, and Rest of Asia Pacific region); Latin America (Brazil, Mexico, and rest of the Latin America); Middle East and Africa (GCC, South Africa, and Rest of the Middle East and Africa).
Global Computational Medicine And Drug Discovery Software Market Taxonomy:
To learn more about this report
Global Computational Medicine And Drug Discovery Software Market Competitive Landscape
The global Computational Medicine And Drug Discovery Software market analysis report covers detailed analysis of competitive scenario across globe. The report includes profiles of leading players covering below details
- Company Overview
- Financial Analysis
- Product Portfolio Analysis
- Strategic Overview
- SWOT Analysis
List of Companies Profiled in the report:
- Entelos
- Genedata
- Crown Bioscience
- Biognos Ab
- Chemical Computing Group
- Leadscope
- Nimbus Therapeutics
- Rhenovia Pharma Limited
- Schrodinger
- Compugen
- Dassault Systemes
- Other Players of Specific Interest can be added based on requirement
Market Segmentation
| Report Attributes |
Details |
| The market size value in 2021 |
USD XX.XX Million |
| CAGR (2021 - 2028) |
XX.XX % |
| The Revenue forecast in 2028 |
USD XX.XX Million |
| Base year for estimation |
2021 |
| Historical data |
2018-2019 |
| Forecast period |
2022-2028 |
| Quantitative units |
- Revenue in USD Million
- CAGR from 2021 to 2028
|
| Report coverage |
Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
| Segments covered |
By Type Outlook, Application Outlook, Regional Outlook |
| By Type Outlook |
Database, Software, Others |
| By Application Outlook |
Computational Physiological Medicine, Drug Discovery And Development, Medical Imaging, Disease Modeling, Predictive Analysis Of Drug Targets, Cellular Simulation, Simulation Software |
| Regional scope |
North America, Europe, Asia Pacific, Latin America, Middle East & Africa |
| Country scope |
U.S., Canada, U.K., Germany, France, BENELUX, China, India, Japan, South Korea, Brazil, Saudi Arabia, UAE, Turkey |
| Key companies profiled |
Entelos, Genedata, Crown Bioscience, Biognos Ab, Chemical Computing Group, Leadscope, Nimbus Therapeutics, Rhenovia Pharma Limited, Schrodinger, Compugen, Dassault Systemes |
| Customization Available |
Yes, the report can be tailored to meet your specific requirements. |
Key Benefits to the stake holders
- Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors
- Provision of market value (USD Billion) and volume (Tons) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry with respect to recent developments (which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes an in-depth analysis of the market of various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
Table Of Contents
Table of Contents
Computational Medicine and Drug Discovery Software Market Report by Company, Regions, Types and Applications, Global Status and Forecast to 2025
1 Industry Overview of Computational Medicine and Drug Discovery Software
1.1 Computational Medicine and Drug Discovery Software Market Overview
1.1.1 Computational Medicine and Drug Discovery Software Product Scope
1.1.2 Market Status and Outlook
1.2 Global Computational Medicine and Drug Discovery Software Market Size and Analysis by Regions
1.2.1 North America
1.2.2 Europe
1.2.3 China
1.2.4 Rest of Asia Pacific
1.2.5 Central & South America
1.2.6 Middle East & Africa
1.3 Computational Medicine and Drug Discovery Software Market by Type
1.3.1 Database
1.3.2 Software
1.3.3 Others
1.4 Computational Medicine and Drug Discovery Software Market by End Users/Application
1.4.1 Computational Physiological Medicine
1.4.2 Drug Discovery And Development
1.4.3 Medical Imaging
1.4.4 Disease Modeling
1.4.5 Predictive Analysis Of Drug Targets
1.4.6 Cellular Simulation
1.4.7 Simulation Software
2 Global Computational Medicine and Drug Discovery Software Competition Analysis by Players
2.1 Computational Medicine and Drug Discovery Software Market Size (Value) by Players (2018 and 2019)
2.2 Competitive Status and Trend
2.2.1 Market Concentration Rate
2.2.2 Product/Service Differences
2.2.3 New Entrants
2.2.4 The Technology Trends in Future
3 Company (Top Players) Profiles
3.1 Entelos
3.1.1 Company Profile
3.1.2 Main Business/Business Overview
3.1.3 Products, Services and Solutions
3.1.4 Computational Medicine and Drug Discovery Software Revenue (Value) (2017-2020)
3.1.5 Recent Developments
3.2 Genedata
3.2.1 Company Profile
3.2.2 Main Business/Business Overview
3.2.3 Products, Services and Solutions
3.2.4 Computational Medicine and Drug Discovery Software Revenue (Value) (2017-2020)
3.2.5 Recent Developments
3.3 Crown Bioscience
3.3.1 Company Profile
3.3.2 Main Business/Business Overview
3.3.3 Products, Services and Solutions
3.3.4 Computational Medicine and Drug Discovery Software Revenue (Value) (2017-2020)
3.3.5 Recent Developments
3.4 Biognos Ab
3.4.1 Company Profile
3.4.2 Main Business/Business Overview
3.4.3 Products, Services and Solutions
3.4.4 Computational Medicine and Drug Discovery Software Revenue (Value) (2017-2020)
3.4.5 Recent Developments
3.5 Chemical Computing Group
3.5.1 Company Profile
3.5.2 Main Business/Business Overview
3.5.3 Products, Services and Solutions
3.5.4 Computational Medicine and Drug Discovery Software Revenue (Value) (2017-2020)
3.5.5 Recent Developments
3.6 Leadscope
3.6.1 Company Profile
3.6.2 Main Business/Business Overview
3.6.3 Products, Services and Solutions
3.6.4 Computational Medicine and Drug Discovery Software Revenue (Value) (2017-2020)
3.6.5 Recent Developments
3.7 Nimbus Therapeutics
3.7.1 Company Profile
3.7.2 Main Business/Business Overview
3.7.3 Products, Services and Solutions
3.7.4 Computational Medicine and Drug Discovery Software Revenue (Value) (2017-2020)
3.7.5 Recent Developments
3.8 Rhenovia Pharma Limited
3.8.1 Company Profile
3.8.2 Main Business/Business Overview
3.8.3 Products, Services and Solutions
3.8.4 Computational Medicine and Drug Discovery Software Revenue (Value) (2017-2020)
3.8.5 Recent Developments
3.9 Schrodinger
3.9.1 Company Profile
3.9.2 Main Business/Business Overview
3.9.3 Products, Services and Solutions
3.9.4 Computational Medicine and Drug Discovery Software Revenue (Value) (2017-2020)
3.9.5 Recent Developments
3.10 Compugen
3.10.1 Company Profile
3.10.2 Main Business/Business Overview
3.10.3 Products, Services and Solutions
3.10.4 Computational Medicine and Drug Discovery Software Revenue (Value) (2017-2020)
3.10.5 Recent Developments
3.11 Dassault Systemes
4 Global Computational Medicine and Drug Discovery Software Market Size by Type and Application (2017-2020)
4.1 Global Computational Medicine and Drug Discovery Software Market Size by Type (2017-2020)
4.2 Global Computational Medicine and Drug Discovery Software Market Size by Application (2017-2020)
4.3 Potential Application of Computational Medicine and Drug Discovery Software in Future
4.4 Top Consumer/End Users of Computational Medicine and Drug Discovery Software
5 North America Computational Medicine and Drug Discovery Software Development Status and Outlook
5.1 North America Computational Medicine and Drug Discovery Software Market Size (2017-2020)
5.2 North America Computational Medicine and Drug Discovery Software Market Size and Market Share by Players (2018 and 2019)
6 Europe Computational Medicine and Drug Discovery Software Development Status and Outlook
6.1 Europe Computational Medicine and Drug Discovery Software Market Size (2017-2020)
6.2 Europe Computational Medicine and Drug Discovery Software Market Size and Market Share by Players (2018 and 2019)
7 China Computational Medicine and Drug Discovery Software Development Status and Outlook
7.1 China Computational Medicine and Drug Discovery Software Market Size (2017-2020)
7.2 China Computational Medicine and Drug Discovery Software Market Size and Market Share by Players (2018 and 2019)
8 Rest of Asia Pacific Computational Medicine and Drug Discovery Software Development Status and Outlook
8.1 Rest of Asia Pacific Computational Medicine and Drug Discovery Software Market Size (2017-2020)
8.2 Rest of Asia Pacific Computational Medicine and Drug Discovery Software Market Size and Market Share by Players (2018 and 2019)
9 Central & South America Computational Medicine and Drug Discovery Software Development Status and Outlook
9.1 Central & South America Computational Medicine and Drug Discovery Software Market Size (2017-2020)
9.2 Central & South America Computational Medicine and Drug Discovery Software Market Size and Market Share by Players (2018 and 2019)
10 Middle East & Africa Computational Medicine and Drug Discovery Software Development Status and Outlook
10.1 Middle East & Africa Computational Medicine and Drug Discovery Software Market Size (2017-2020)
10.2 Middle East & Africa Computational Medicine and Drug Discovery Software Market Size and Market Share by Players (2018 and 2019)
11 Market Forecast by Regions, Type and Application (2021-2027)
11.1 Global Computational Medicine and Drug Discovery Software Market Size (Value) by Regions (2021-2027)
11.1.1 North America Computational Medicine and Drug Discovery Software Revenue and Growth Rate (2021-2027)
11.1.2 Europe Computational Medicine and Drug Discovery Software Revenue and Growth Rate (2021-2027)
11.1.3 China Computational Medicine and Drug Discovery Software Revenue and Growth Rate (2021-2027)
11.1.4 Rest of Asia Pacific Computational Medicine and Drug Discovery Software Revenue and Growth Rate (2021-2027)
11.1.5 Central & South America Computational Medicine and Drug Discovery Software Revenue and Growth Rate (2021-2027)
11.1.6 Middle East & Africa Computational Medicine and Drug Discovery Software Revenue and Growth Rate (2021-2027)
11.2 Global Computational Medicine and Drug Discovery Software Market Size (Value) by Type (2021-2027)
11.3 Global Computational Medicine and Drug Discovery Software Market Size by Application (2021-2027)
12 Computational Medicine and Drug Discovery Software Market Dynamics
12.1 Computational Medicine and Drug Discovery Software Market Opportunities
12.2 Computational Medicine and Drug Discovery Software Challenge and Risk
12.2.1 Competition from Opponents
12.2.2 Downside Risks of Economy
12.3 Computational Medicine and Drug Discovery Software Market Constraints and Threat
12.3.1 Threat from Substitute
12.3.2 Government Policy
12.3.3 Technology Risks
12.4 Computational Medicine and Drug Discovery Software Market Driving Force
12.4.1 Growing Demand from Emerging Markets
12.4.2 Potential Application
13 Market Effect Factors Analysis
13.1 Technology Progress/Risk
13.1.1 Substitutes
13.1.2 Technology Progress in Related Industry
13.2 Consumer Needs Trend/Customer Preference
13.3 External Environmental Change
13.3.1 Economic Fluctuations
13.3.2 Other Risk Factors
14 Research Finding/Conclusion
15 Appendix
Methodology
Analyst Introduction
Data Source
